WT1 dendritic cell vaccine (Antwerp University Hospital)

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameWT1 dendritic cell vaccine (Antwerp University Hospital)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMesotheliomaLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesAntwerp University Hospital

China Registration ClassN/A

Develop Information

Active CompaniesAntwerp University Hospital

Inactive CompaniesN/A

Active IndicationsMesotheliomaLeukemia, Myeloid, Acute

Inactive IndicationsN/A

Other Information

ATC CodeN/A